Bobak R. Azamian - Mar 24, 2025 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role: President/CEO and Board Chair, Director
Signature: /s/ Jeffrey Farrow, Attorney-in-Fact
Stock symbol: TARS
Transactions as of: Mar 24, 2025
Transactions value $: -$300,000
Form type: 4
Date filed: 3/26/2025, 04:47 PM
Previous filing: Mar 20, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TARS	Common Stock	Sale	-$300K	-6K	-0.72%	$50.00	824K	Mar 24, 2025	By the Bobak Azamian Living Trust established April 16, 2018	F1, F2
holding	TARS	Common Stock						53.6K	Mar 24, 2025	Direct

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2024.
F2	The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.